Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Q: Paragraph: The governor, who is also a pediatric neurologist, worked to comfort victims of Friday’s shooting and their families, while helping coordinate the massive government response. He discussed the shooting with President Donald Trump in a private phone call, stood shoulder to shoulder with other elected officials at a news conference and pressed for tighter gun control to national audiences. The subject of widespread mockery after the racist photo from his medical school yearbook surfaced, the Democratic governor appears determined to project that he’s up to the task. “Actions speak a lot louder than words. And I will have the leadership that’s needed,” Northam said in an interview with NPR after the shooting, while discussing potential plans to push for increased gun regulations. Police said 12 people were killed and several others injured when DeWayne Craddock, an engineer with the city’s utilities department, opened fire inside a municipal building Friday afternoon. Northam quickly left Richmond after the shooting and drove to Virginia Beach, speaking to local, state and other officials on the way down to coordinate responses and share information. After a news conference Friday evening, Northam took a call from Trump to discuss the shooting, with the president offering the federal government’s full support. Michael Berlucchi, a Virginia Beach City Council member, praised the governor and other officials for their work to address the shooting’s aftermath from the city’s emergency operations center. “Nobody carried their baggage into that room,” Berlucchi said Sunday. “The only thing I saw was public servants coming together to address the worst tragedy in the history of our city.” On Saturday, Northam attended a vigil at a church where he told those gathered that “God is in control.” He visited a hospital to meet with survivors and thank doctors and staff. In broadcast interviews with national media, Northam stressed the need for action to prevent similar deadly shootings. “We lost 12 lives yesterday. If you look at the commonwealth of Virginia, we lost over 900 lives over the past two years to gun violence, gun-related accidents,” Northam said on CNN. “So I will make decisions in the upcoming days but we need to look at our laws: are they safe, do they keep people protected in the Commonwealth of Virginia?” The governor has long been an advocate for stricter gun control. He made the issue a top priority of his 2017 gubernatorial campaign, drawing from his experience as a pediatrician and Army doctor who has treated children and soldiers wounded by firearms. But a package of bills Northam pushed this year, including legislation to limit gun magazine size and give local governments broader authority to ban guns in city buildings, went nowhere in a staunchly pro-gun Republican-controlled Virginia General Assembly. Northam hinted Saturday in media interviews that he may be considering some kind of executive action related to gun control efforts that would bypass the legislature, but his office declined to say what specific actions he may take. Any dramatic moves by the governor would face stiff resistance from his political opponents. Philip Van Cleave, president of the Virginia Citizens Defense League, said Northam doesn’t have any real power to impose new gun limits and any efforts to do so would be an attempt to deflect attention away his scandal. “He’d be very happy to try and change the focus away from the blackface stuff,” Van Cleave said. Northam has been battling for months to regain a sense of normalcy in office after a picture surfaced in February of man in blackface and another person wearing a Ku Klux Klan outfit on his medical school yearbook page. Northam has denied being in the picture, and investigators recently said they can’t conclusively establish the identities of either person in the 35-year-old photo. The governor withstood widespread pressure for him to resign, which weakened after scandal soon enveloped his potential successors . Two women publicly accused Lt. Gov. Justin Fairfax of sexual assault, which he denies, and Attorney General Mark Herring announced he’d also worn blackface in college, just days after calling on Northam to resign. Both Fairfax and Herring have also resisted calls to resign. Fairfax was also in Virginia Beach after the shooting. He attended a church service Sunday where and pledged to take “serious action” to prevent future mass shootings. “I think that thoughts and prayers from politicians are not enough,” Fairfax said. “We’ve had too many thoughts and prayers over the years and we’ve not acted in the ways to prevent these mass shootings in the future.” ___ This story has been corrected to say pediatrician, not pedestrian. ___ Contributors include Associated Press writer Ben Finley. Claim: Shooting poses Virginia governor’s first test since scandal.

A: Virginia Gov. Ralph Northam wasted little time getting to Virginia Beach after a gunman killed a dozen people in a city office building, the first major test of his leadership since a blackface scandal almost forced him from office four months ago.
****
Q: Paragraph: A GlaxoSmithKline logo is seen outside one of its buildings in west London, February 6, 2008. REUTERS/Toby Melville The GlaxoSmithKline Plc vaccine Rotarix fights infection with the rotavirus, which causes about 55,000 hospitalizations in U.S. children each year and kills more than 600,000 children worldwide, mostly in developing countries. Rotarix already is approved in more than 100 other countries throughout the world. The vaccine competes with Merck & Co Inc’s rotavirus vaccine called RotaTeq. Without vaccination, nearly every child in the United States likely would be infected at least once with rotavirus by age five, the Food and Drug Administration said. In studies of more than 24,000 infants, Rotarix prevented severe and mild cases of rotavirus-caused diarrhea and vomiting during the first two years of life. “This vaccine provides another option to combat and reduce a potentially severe illness that affects so many children,” Dr. Jesse Goodman, director of the FDA’s Center for Biologics Evaluation and Research, said in a statement announcing the Rotarix approval. The most common reactions reported during clinical trials were fussiness, irritability, cough, runny nose, fever, loss of appetite and vomiting, the FDA said. An earlier oral rotavirus vaccine sold by Wyeth was pulled from the market in 1999 after it was linked to a rare, life-threatening type of bowel obstruction known as intussusception. In a Glaxo study of more than 63,000 infants, there was no increase in the problem compared with a placebo. Higher rates of convulsion and pneumonia-related deaths were seen in Rotarix patients in that study but not in other Glaxo trials. “Although the FDA has concluded that the available data do not establish that these events are related to the vaccine, the agency has requested the manufacturer to conduct post-marketing safety studies involving more than 40,000 infants to provide additional safety information,” the FDA said. Glaxo said Rotarix “will offer protection against the most commonly circulating rotavirus types in the U.S. and allow infants to complete the vaccination series by four months of age.”   Rotarix, which is a liquid, is given in two doses to infants from six to 24 weeks of age, the FDA said. Merck’s RotaTeq vaccine is administered in three doses from ages six weeks to 32 weeks. Sales of Rotarix were $182 million in 2007 and are expected to rise with approval in the large U.S. market. The vaccine will be commercially available in the United States in the second half of the year, Glaxo said. Also on Thursday, researchers reported that Rotarix provided protection for up to two years in a study of infants from 10 Latin American countries. The Glaxo-funded trial of more than 15,000 infants found severe diarrhea from rotavirus in 0.4 percent of children given the vaccine, compared with 2.3 percent in the placebo group. Results were published in the Lancet medical journal. The arrival of a new generation of oral vaccines against the disease has been welcomed by health-care workers, but some experts caution against assuming the vaccines will work equally well in all countries. In a commentary in the Lancet, Australian pediatric experts Keith Grimwood and Carl Kirkwood noted Rotarix was more effective in European trials than in middle-income Latin American countries. The World Health Organization “is awaiting efficacy data from low-income countries of Africa and Asia, where much greater strain diversity exists and where 413,000 deaths occur every year compared with 15,000 in Latin America and 200 in Europe,” Grimwood and Kirkwood wrote. Claim: Glaxo wins FDA clearance for rotavirus vaccine.

A: A second oral vaccine to prevent a leading cause of severe diarrhea in infants won approval from U.S. health officials on Thursday.
****
Q: Paragraph: Once an illness is added to the list of approved conditions, the board cannot remove it because state law does not give the board authority to do so, according to board spokeswoman Tessie Pollock. Petitions will be reviewed early next year. AIDS, Alzheimer’s disease, and Amyotrophic lateral sclerosis, or ALS, are among the 21 current approved illnesses, along with cancer, epilepsy, glaucoma and Parkinson’s disease. Earlier this year the board rejected petitions seeking to add anxiety and autism spectrum disorders as qualifying conditions. The board will for the first time open up a public comment period, beginning after its Jan. 8 meeting, said executive director Stephanie Louka. Final decisions on new accepting conditions would come after several months. ___ This story was first published on Dec. 25, 2019. It was updated on Dec. 27, 2019, to correct the name of the State Medical Board of Ohio spokeswoman. She is Tessie Pollock, not Tessa Pollock. It was also updated to clarify that the board says state law does not give it the authority to remove conditions from the list of approved conditions for which doctors can recommend medical marijuana to patients. Claim: Board to consider new conditions for medical marijuana use.

A:
The state Medical Board is accepting new petitions through the end of the year from those seeking to add illnesses as qualifying conditions for physicians to recommend medical marijuana to Ohio patients, cleveland.com reported.
****